Ramelteon Tablet
Product Images NDC 80425-0593

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ramelteon (NDC 80425-0593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ramelteon 8mg # 30 (Ramelteon 8mg 80425 0593 01)

Label for Ramelteon 8 mg oral tablets, packaged by Advanced Rx of Tennessee, LLC in Nashville. The label indicates a 30-count package with comparisons to Rozerem, includes NDCs 80425-0593-01 and source NDC 42571-0375-30, with expiration date 10/31/2030. Storage instructions specify keeping the product between 20° and 25°C (68° and 77°F). The label features barcodes and lot number placeholders.*

FDA Label Image

Ramelteon-structure.jpg (Ramelteon Structure)

Chemical structure of ramelteon showing its molecular formula layout including a fused bicyclic ring with an oxygen-containing five-membered ring and an ethylcarbamoyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.